![L.R. Fox of NEXT Life Sciences and Elaine Lissner of the Parsemus Foundation](https://www.parsemus.org/wp-content/uploads/2024/07/elaine-fox-2-300x217.jpg)
Passing the Vasalgel torch
Two years ago, the Parsemus Foundation partnered with NEXT Life Sciences to prepare Vasalgel — the non-hormonal, long-lasting, and reversible male contraceptive — for human
Two years ago, the Parsemus Foundation partnered with NEXT Life Sciences to prepare Vasalgel — the non-hormonal, long-lasting, and reversible male contraceptive — for human
The IRONMAN randomized clinical trial reported that treatment with intravenous iron for individuals with heart failure and iron deficiency resulted in a lower risk of
The World Small Animal Veterinary Association (WSAVA) has published a comprehensive guidance document on reproductive control in cats and dogs, and it’s a must-have for
Early detection and treatment are important to fighting Alzheimer’s disease. Three recent studies offer promising developments in identifying, preventing and potentially treating Alzheimer’s. Blood tests
Traditionally, low-density lipoprotein cholesterol (LDL-C), the so-called “bad cholesterol,” has been used as a primary indicator of cardiovascular disease (CVD) risk. However, recent advancements have
Looking for info that puts your health, not profits, first? Parsemus Foundation is proud to announce Hormonally.org, a comprehensive resource hub offering expert-backed insights, articles, and tools designed
Go to Amici Cannis Donate now Looking to support a reputable animal rescue organization? Amici Cannis is one of the Parsemus Foundation’s favorite animal welfare
A first-of-its-kind hormone-free birth control pill for men shows promise in a clinical trial. Here’s news about YCT-529, a drug you may hear more about
Overused, unnecessary, or low-value healthcare options can have significant negative effects on patients, providers, and the healthcare system. This is partly due to cascading effects
A recent publication in Scientific Reports took an in-depth look at longevity in Rottweilers. The authors evaluated the health records of 7,185 Rottweiler dogs from
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: